Riskpilot← Back to searchSign inGet full accessNovi Formula AB
ABActiveOrg 5593129207Smedsbacksgatan 12 1202Manufacture of homogenised food preparations and dietetic food · NACE 1086Est. 20210 employees
Revenue 2024
—
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit 2024
—
0 employees
| Revenue | — | — |
| EBITDA | SEK 0 | — |
| Net profit | — | — |
| Total assets | — | — |
| Equity | — | — |
| Employees | 0 | — |
Legal name
Novi Formula AB
Org number
5593129207
Legal form
Aktiebolag
NACE code
1086 · Manufacture of homogenised food preparations and dietetic food
Founded
19 april 2021
Share capital
SEK 0
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Verksamheten skapar och säljer näringstillskott med syfte att låta människor få ut mer utav varje dag. Verksamheten samarbetar med producenter inom nutraceuticals, naturliga råvaror, och kosttillskott för att ta fram nytänkande produkter i detta syfte. Verksamheten har som ambition att bli en internationell aktör på sikt.
Address
Smedsbacksgatan 12 1202
Email
samuel.oqvist@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Staff expenses | — | — | — | — |
| EBITDA | 0 | 0 | 0 | 0 |
| Depreciation & amort. | — | — | — | — |
| EBIT | 0 | 0 | 0 | 0 |
| Net financials | — | — | — | — |
| Profit before tax | 0 | 0 | 0 | 0 |
| Tax | — | — | — | — |
| Net profit | — | — | — | — |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | — | — | — | — |
| Equity | — | — | — | — |
| Long-term debt | — | — | — | — |
| Short-term debt | — | — | — | — |
| Total debt | — | — | — | — |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20212024
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
20212024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20212024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
-1.00×
This company
0.62×
Market median
+261% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-04-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Novi Formula AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Johan Mikael Öquist | Deputy Board Member | 0 companies |
| David Samuel Edward Paul Öquist | Board of Directors | 0 companies |